Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) will be announcing its earnings results after the market closes on Monday, November 11th. Analysts expect the company to announce earnings of $0.57 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last posted its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.01. The business had revenue of $48.95 million during the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a net margin of 51.61% and a return on equity of 12.03%. During the same period in the prior year, the business posted $0.56 earnings per share. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Crescent Capital BDC Stock Down 0.9 %
CCAP opened at $18.02 on Monday. Crescent Capital BDC has a 12 month low of $15.91 and a 12 month high of $19.63. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.17. The business’s 50-day moving average price is $18.42 and its 200-day moving average price is $18.36. The company has a market cap of $667.82 million, a P/E ratio of 6.55 and a beta of 0.81.
Crescent Capital BDC Increases Dividend
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the stock. Wells Fargo & Company cut their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 14th. LADENBURG THALM/SH SH started coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 price target on the stock. Finally, Bank of America lowered their price objective on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 15th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $19.00.
Read Our Latest Analysis on Crescent Capital BDC
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Further Reading
- Five stocks we like better than Crescent Capital BDC
- EV Stocks and How to Profit from Them
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Ride Out The Recession With These Dividend Kings
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Manufacturing Stocks Investing
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.